| RS1553192091 |
ATP1A1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-tooth disease, axonal |
| RS1553192420 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1553192432 |
ABCA4
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1553192682 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Macular dystrophy, Retinal dystrophy |
| RS1553192715 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1553192718 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553192726 |
ABCA4
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1553192783 |
ATP1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-tooth disease, axonal |
| RS1553193463 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553193485 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS1553193486 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553193507 |
NOTCH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS1553193524 |
NOTCH2
|
Health Risk |
Pathogenic |
— |
| RS1553193529 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553193530 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1553193574 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS1553193813 |
ABCA4
|
Health Risk |
Pathogenic |
Retinal dystrophy, Cone-rod dystrophy 3 |
| RS1553193910 |
COL11A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marshall syndrome, Stickler syndrome type 2 |
| RS1553193913 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS1553193977 |
NOTCH2
|
Health Risk |
Pathogenic |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS1553194093 |
NOTCH2
|
Health Risk |
Pathogenic |
— |
| RS1553194155 |
GNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 42 |
| RS1553194162 |
GNB1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Intellectual disability |
| RS1553194472 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, Hajdu-Cheney syndrome |
| RS1553195472 |
ABCA4
|
Health Risk |
Likely pathogenic |
Macular dystrophy, Macular dystrophy |
| RS1553195867 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, Alagille syndrome due to a NOTCH2 point mutation |
| RS1553195973 |
NOTCH2
|
Health Risk |
Pathogenic |
— |
| RS1553196068 |
ALX3
|
Health Risk |
Likely pathogenic |
Frontorhiny, Frontorhiny |
| RS1553196096 |
CDC42
|
Health Risk |
Pathogenic |
Postnatal growth retardation, Neurodevelopmental abnormality |
| RS1553196100 |
CDC42
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome, Abnormality of the immune system |
| RS1553196101 |
CDC42
|
Health Risk |
Pathogenic |
Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome, Neurodevelopmental abnormality |
| RS1553196119 |
CDC42
|
Health Risk |
Likely pathogenic |
— |
| RS1553196134 |
CDC42
|
Health Risk |
Pathogenic |
Neurodevelopmental abnormality, Postnatal growth retardation |
| RS1553196233 |
COL11A1
|
Health Risk |
Likely pathogenic |
Hearing impairment, Hearing loss |
| RS1553196515 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Connective tissue disorder |
| RS1553196539 |
CDC42
|
Health Risk |
Pathogenic |
Noonan-like syndrome, Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome |
| RS1553196583 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1553196764 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1553196900 |
CTSK
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1553196906 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1553196934 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1553196945 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1553197230 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1553197239 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1553197262 |
CTSK
|
Health Risk |
Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS1553197926 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1553197939 |
CASQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Wolff-Parkinson-White pattern, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1553198611 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1553199298 |
NOTCH2
|
Health Risk |
Pathogenic |
— |
| RS1553199845 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, Alagille syndrome due to a NOTCH2 point mutation |
| RS1553200134 |
NOTCH2
|
Health Risk |
Pathogenic |
— |
| RS1553200431 |
COL11A1
|
Health Risk |
Likely pathogenic |
8 conditions, 8 conditions |
| RS1553200766 |
DARS2
|
Health Risk |
Pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS1553200868 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS1553200990 |
NPHP4
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis 4, Nephronophthisis |
| RS1553201258 |
DARS2
|
Health Risk |
Pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Dysmetria |
| RS1553201443 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1553201476 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1553201582 |
SLC35A3
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS1553202301 |
NOTCH2
|
Health Risk |
Likely pathogenic |
— |
| RS1553202681 |
DARS2
|
Health Risk |
Likely pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS1553203137 |
SLC35A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS1553204327 |
DARS2
|
Health Risk |
Pathogenic |
— |
| RS1553204817 |
SELENBP1
|
Health Risk |
Likely pathogenic |
Extra oral halitosis, Extraoral halitosis due to methanethiol oxidase deficiency |
| RS1553204840 |
SELENBP1
|
Health Risk |
Likely pathogenic |
Extra oral halitosis, Extraoral halitosis due to methanethiol oxidase deficiency |
| RS1553207540 |
ADAR
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 6, Aicardi-Goutieres syndrome 6 |
| RS1553208520 |
SLC16A1
|
Health Risk |
Pathogenic |
— |
| RS1553209362 |
PSMB4
|
Health Risk |
Pathogenic |
Proteasome-associated autoinflammatory syndrome 3, Proteasome-associated autoinflammatory syndrome 3 |
| RS1553209373 |
PSMB4
|
Health Risk |
Pathogenic |
Proteasome-associated autoinflammatory syndrome 1, Proteasome-associated autoinflammatory syndrome 1 |
| RS1553210405 |
NCSTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Acne inversa, familial |
| RS1553210984 |
NCSTN
|
Health Risk |
Pathogenic |
Acne inversa, familial |
| RS1553211087 |
NCSTN
|
Health Risk |
Pathogenic |
Acne inversa, familial |
| RS1553211362 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS1553211449 |
ADAR
|
Health Risk |
Pathogenic |
— |
| RS1553211899 |
SLC19A2
|
Health Risk |
Pathogenic |
Megaloblastic anemia, thiamine-responsive |
| RS1553212090 |
ADAR
|
Health Risk |
Pathogenic |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS1553212204 |
POGZ
|
Health Risk |
Likely pathogenic |
— |
| RS1553212374 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1553212545 |
POGZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1553212596 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1553212626 |
POGZ
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553212757 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1553212868 |
POGZ
|
Health Risk |
Likely pathogenic |
17 conditions, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1553212978 |
POGZ
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553213060 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1553213126 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1553213136 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS1553213240 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1553213268 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1553213659 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1553215684 |
GPSM2
|
Health Risk |
Likely pathogenic |
— |
| RS1553216467 |
POGZ
|
Health Risk |
Pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1553216524 |
GPSM2
|
Health Risk |
Pathogenic |
Chudley-McCullough syndrome, Chudley-McCullough syndrome |
| RS1553216985 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease, Gaucher disease |
| RS1553217009 |
GBA1
|
Health Risk |
Likely pathogenic |
Gaucher disease, Parkinson disease |
| RS1553217294 |
GBA1
|
Health Risk |
Likely pathogenic |
Gaucher disease, 7 conditions |
| RS1553217314 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease, Gaucher disease |
| RS1553217626 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease, Gaucher disease |
| RS1553217879 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease, Gaucher disease |
| RS1553217946 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease type I, Gaucher disease type I |